Therapeutic Group: Oncology Presentation Palbocent 125: Each capsule contains Palbociclib INN 125 mg. Description Palbociclib is an inhibitor of cyclin-dependent kinases (CDK) 4 and 6. Cyclin D1 and CDK4/6 are downstream of signaling pathways which lead to cellular proliferation. In vitro, Palbociclib reduced cellular proliferation of estrogen receptor (ER)-positive breast cancer cell lines by blocking […]